The global axial spondyloarthritis treatment market 2018-2022 is expected to post a CAGR of more than 7% during the forecast period, according to the latest market research report by Technavio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181019005403/en/
Technavio analysts predict the global axial spondyloarthritis treatment market to post a CAGR of more than 7% by 2022. (Graphic: Business Wire)
A key factor driving the growth of the market is the rise in the prevalence of axial spondyloarthritis. Axial spondyloarthritis is affecting people across the globe. According to the National Ankylosing Spondylitis Society, it is estimated that approximately 200,000 people are affected by ankylosing spondylitis in the UK. In 2012 alone, it was observed that around 6% of the UK adults develop chronic low back pain, which is the main symptom of axial spondylitis.
This market research report on the global axial spondyloarthritis treatment market 2018-2022 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
In this report, Technavio highlights the growing strategic alliances as one of the key emerging trends in the global axial spondyloarthritis treatment market:
Global axial spondyloarthritis treatment market: Growing strategic alliances
Vendors in the global axial spondyloarthritis treatment market are regularly engaging in the strategic alliances to strengthen their market position. For instance, Biogen and Samsung Bioepis entered into an agreement with AbbVie for the commercialization of IM RALDI.
“Alliances help the vendors consolidate their position, extend their geographical reach, and expand their product line offerings, which will support the growth of the global axial spondyloarthritis treatment market during the forecast period. These collaborations and partnerships also help vendors develop products at a rapid pace and ensure that there are no restraints on the product development funds,” says a senior analyst at Technavio.
Global axial spondyloarthritis treatment market: Segmentation analysis
This market research report segments the global axial spondyloarthritis treatment market by end-user (ankylosing spondylitis and non-radiographic axial spondyloarthritis) and geographical regions (APAC, EMEA, and the Americas).
The Americas led the market in 2017 with a market share of close to 43%, followed by APAC and EMEA respectively. The Americas is expected to continue to dominate the market during the forecast period. The presence of the US, which is the largest pharmaceutical market, is the main factor driving the growth of the market in this region. However, APAC leads the market in terms of growth rate, owing to the large population base, the growing geriatric population, and the improving healthcare infrastructure in the market.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181019005403/en/
Contacts:
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com
